Evaluation of carcinogenic risk of PUVA versus Re-PUVA in psoriatic patients

Conclusion: Re-PUVA was able to achieve the same clinical response as PUVA in psoriasis patients, but with an earlier onset of clinical response, lower UVA cumulative dose, less DNA damage in the serum, and hence a lower carcinogenic potential.
Source: Journal of the Egyptian Women’s Dermatologic Society - Category: Dermatology Tags: Original articles Source Type: research